Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 2
2012 1
2013 1
2015 8
2016 10
2017 16
2018 20
2019 13
2020 17
2021 21
2022 15
2023 11
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

124 results

Results by year

Filters applied: . Clear all
Page 1
Assessment of the safety of nivolumab in people living with HIV with advanced cancer on antiretroviral therapy: the AIDS Malignancy Consortium 095 Study.
Rajdev L, Jackie Wang CC, Joshi H, Lensing S, Lee J, Ramos JC, Baiocchi R, Ratner L, Rubinstein PG, Ambinder R, Henry D, Streicher H, Little RF, Chiao E, Dittmer DP, Einstein MH, Cesarman E, Mitsuyasu R, Sparano JA; AIDS Malignancy Consortium. Rajdev L, et al. Cancer. 2024 Mar 15;130(6):985-994. doi: 10.1002/cncr.35110. Epub 2023 Nov 14. Cancer. 2024. PMID: 37962072
Two-Year Incidence and Cumulative Risk and Predictors of Anal High-Grade Squamous Intraepithelial Lesions (Anal Precancer) Among Women With Human Immunodeficiency Virus.
Stier EA, Jain M, Joshi H, Darragh TM, Deshmukh AA, Lee J, Einstein MH, Jay N, Berry-Lawhorn JM, Palefsky JM, Wilkin T, Ellsworth G, French AL, Barroso LF, Levine R, Guiot HM, Rezaei MK, Chiao E. Stier EA, et al. Clin Infect Dis. 2024 Mar 20;78(3):681-689. doi: 10.1093/cid/ciad614. Clin Infect Dis. 2024. PMID: 37805952
Brentuximab vedotin with AVD for stage II-IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial.
Rubinstein PG, Moore PC, Bimali M, Lee JY, Rudek MA, Chadburn A, Ratner L, Henry DH, Cesarman E, DeMarco CE, Costagliola D, Taoufik Y, Ramos JC, Sharon E, Reid EG, Ambinder RF, Mitsuyasu R, Mounier N, Besson C, Noy A; AIDS Malignancy Consortium; Lymphoma Study Association. Rubinstein PG, et al. Lancet Haematol. 2023 Aug;10(8):e624-e632. doi: 10.1016/S2352-3026(23)00157-6. Lancet Haematol. 2023. PMID: 37532416 Clinical Trial.
Phase I Trial of the Multi-kinase Inhibitor Cabozantinib, a CYP3A4 Substrate, plus CYP3A4-Interacting Antiretroviral Therapy in People Living with HIV and Cancer (AMC-087).
Haigentz M Jr, Lee JY, Chiao EY, Aboulafia DM, Ratner L, Ambinder RF, Baiocchi RA, Mitsuyasu RT, Wachsman W, Sparano JA, Rudek MA. Haigentz M Jr, et al. Clin Cancer Res. 2023 Dec 15;29(24):5038-5046. doi: 10.1158/1078-0432.CCR-23-1142. Clin Cancer Res. 2023. PMID: 37523145 Clinical Trial.
Construct validity and responsiveness of a health-related symptom index for persons either treated or monitored for anal high-grade squamous intraepithelial lesions (HSIL): AMC-A01/-A03.
Atkinson TM, Lensing S, Lee JY, Chang D, Kim SY, Li Y, Lynch KA, Webb A, Holland SM, Lubetkin EI, Goldstone S, Einstein MH, Stier EA, Wiley DJ, Mitsuyasu R, Rosa-Cunha I, Aboulafia DM, Dhanireddy S, Schouten JT, Levine R, Gardner E, Logan J, Dunleavy H, Barroso LF, Bucher G, Korman J, Stearn B, Wilkin TJ, Ellsworth G, Pugliese JC, Arons A, Burkhalter JE, Cella D, Berry-Lawhorn JM, Palefsky JM. Atkinson TM, et al. Qual Life Res. 2023 Aug;32(8):2293-2304. doi: 10.1007/s11136-023-03391-4. Epub 2023 Apr 5. Qual Life Res. 2023. PMID: 37020153 Free PMC article. Clinical Trial.
Cancer-Related Stigma in Malawi: Narratives of Cancer Survivors.
Watt MH, Suneja G, Zimba C, Westmoreland KD, Bula A, Cutler L, Khatri A, Painschab MS, Kimani S. Watt MH, et al. JCO Glob Oncol. 2023 Feb;9:e2200307. doi: 10.1200/GO.22.00307. JCO Glob Oncol. 2023. PMID: 36795989 Free PMC article.
Intra-Host Evolution Provides for the Continuous Emergence of SARS-CoV-2 Variants.
Landis JT, Moorad R, Pluta LJ, Caro-Vegas C, McNamara RP, Eason AB, Bailey A, Villamor FCS, Juarez A, Wong JP, Yang B, Broussard GS, Damania B, Dittmer DP. Landis JT, et al. mBio. 2023 Apr 25;14(2):e0344822. doi: 10.1128/mbio.03448-22. Epub 2023 Feb 14. mBio. 2023. PMID: 36786605 Free PMC article.
124 results